|
|
||||||||
Vascular Biology Group, Division of Experimental Pathophysiology and Immunology, Department Biocenter, Innsbruck Medical University, Innsbruck, Austria
1 Correspondence: Vascular Biology Group, Division of Experimental Pathophysiology and Immunology, Department Biocenter, Innsbruck Medical University, Fritz-Pregl-Str. 3/4. OG. 6020 Innsbruck, Austria. E-mail: David.Bernhard{at}uibk.ac.at
Smoking is a significant risk factor for development of atherosclerosis. However, the pathophysiology of smoking-mediated vessel wall damage is not understood. With tools ranging from analytical chemistry to cell biology, we show that cigarette smoke contains metals that catalyze the direct oxidation of cellular proteins by smoke oxidants. Oxidation of cellular proteins causes a loss of microtubule function, culminating in microtubule depolymerization and proteasome-dependent degradation of
-tubulin. As a consequence of the microtubule collapse, cytoskeletal structures as well as intermediate filaments break down, leading finally to a contraction of vascular endothelial cells. We observed a smoke extract-induced, calpain-dependent degradation of the intracellular form of platelet-endothelial cell adhesion molecule 1/CD31, as well as a release of P-selectin/CD62P, IL-6, and IL-8 from endothelial cells into the supernatant. Increased levels of soluble CD62P and IL-6 are well known to be associated with smoking in humans. Increased permeability of the vascular endothelium is a crucial event in atherogenesis. This work highlights the compounds and mechanisms by which cigarette smoke induces leakiness of the vascular endothelium.Bernhard, D., Csordas, A., Henderson, B., Rossmann, A., Kind, M., Wick, G. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules.
Key Words: cigarette smoke extract endothelial atherosclerosis microtubules oxidative stress cytokines/chemokines
This article has been cited by other articles:
![]() |
D. Aradi, A. Konyi, L. Palinkas, T. Berki, T. Pinter, T. Tahin, I. Horvath, L. Papp, and A. Komocsi Thienopyridine Therapy Influences Late Outcome After Coronary Stent Implantation Angiology, May 1, 2008; 59(2): 172 - 178. [Abstract] [PDF] |
||||
![]() |
S. S. Barbieri, L. Ruggiero, E. Tremoli, and B. B. Weksler Suppressing PTEN Activity by Tobacco Smoke Plus Interleukin-1{beta} Modulates Dissociation of VE-Cadherin/{beta}-Catenin Complexes in Endothelium Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain Diabetes, July 1, 2007; 56(7): 1842 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Barbieri and B. B. Weksler Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo FASEB J, June 1, 2007; 21(8): 1831 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Cantin, J. W. Hanrahan, G. Bilodeau, L. Ellis, A. Dupuis, J. Liao, J. Zielenski, and P. Durie Cystic Fibrosis Transmembrane Conductance Regulator Function Is Suppressed in Cigarette Smokers Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1139 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bernhard, A. Rossmann, B. Henderson, M. Kind, A. Seubert, and G. Wick Increased Serum Cadmium and Strontium Levels in Young Smokers: Effects on Arterial Endothelial Cell Gene Transcription Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 833 - 838. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |